Ibrance Coupons & Savings Card – Discount Prices from $13955.79

Ibrance is not considered traditional chemotherapy. It is a targeted therapy known as a CDK4/6 inhibitor, which works by interfering with specific proteins involved in the growth and division of cancer cells. It is often used in combination with other treatments for certain types of breast cancer.

Ibrance is used in the treatment of certain types of breast cancer. It is typically prescribed for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, often in combination with hormone therapy.

The most common side effect of Ibrance (palbociclib) is neutropenia, which is a decrease in the number of neutrophils, a type of white blood cell important for fighting infections.

Ibrance side effects can vary in duration and intensity among individuals. Some side effects may diminish as the body adjusts to the medication, while others might persist throughout the treatment. Common side effects like fatigue, nausea, and hair thinning may improve over time. However, more serious side effects, such as low blood cell counts, require monitoring and may necessitate medical intervention. It is important for patients to discuss any persistent or concerning side effects with their healthcare provider to manage them effectively.

Yes, Ibrance (palbociclib) is considered a type of targeted cancer therapy, which is a form of chemotherapy. It specifically targets certain proteins in cancer cells to inhibit their growth and proliferation.